NACDS Comments to SAMHSA Highlight the Critical Role of Pharmacies in Expanding Access to Opioid Use Disorder Treatment Services Call on SAMHSA to help ensure that the regulatory framework for medications for opioid use disorder treatment continues to accommodate evolving practice models that deliver treatment services in new and innovative ways – and in different patient care settings

2023-02-16T14:22:46-05:00Categories: Press Release|Tags: , , , |

Call on SAMHSA to help ensure that the regulatory framework for medications for opioid use disorder treatment continues to accommodate evolving practice models that deliver treatment services in new and innovative ways – and in different patient care settings.

NACDS Urges Mandatory Electronic Prescriptions for Controlled Substances Comments to DEA call electronic prescribing an “important tool to improve patient health outcomes and combat the misuse, abuse, and diversion of controlled substances”

2020-06-26T15:19:44-04:00Categories: Press Release|Tags: , |

NACDS is urging the DEA to make electronic prescriptions for controlled substances (EPCS) mandatory.

During Pharmacists Month, NACDS Affirms Commitment to Opioid Abuse Prevention and Pain Care NACDS deploying its 30-second message regarding pharmacy’s commitment, and recognizing pharmacists’ dedication, to serve as part of the solution

2019-09-24T13:59:37-04:00Categories: Press Release|Tags: , , |

NACDS is deploying its 30-second message regarding pharmacy’s commitment, and recognizing pharmacists’ dedication, to serve as part of the solution.

Go to Top